Procept BioRobotics today announced the international rollout of its next-generation Hydros robotic system for Aquablation therapy.

Discusses First Clinical Outcomes and Precision of TULSA from the CAPTAIN Trial in Prostate Cancer March 13, 2026 11:30 ...

Drs Uzzo, Chung, and Croll of Fox Chase Cancer Center at Temple University Health discuss top presentations from the ASCO Genitourinary Cancers Symposium 2026. The American Society of Clinical ...

It is used both to treat tumours and to help clinicians determine whether they are cancerous, as well as their grade and ...

Sivelestat significantly reduced the incidence of postoperative ARDS, lowered 90-day mortality, and suppressed inflammatory biomarkers linked to lung injury.

The authors have declared no conflicts of interest. The patient provided informed consent for the publication of this case report. Acknowledgements: Gupta was involved in writing the original draft, ...